What is NDC 69489-111?

69489-111 is the product NDC for Targadox (doxycycline hyclate), Doxycycline hyclate 50 mg/1 tablet, listed with the FDA by Journey Medical Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Targadox (Doxycycline hyclate).

Journey Medical Corporation, NDC labeler code 69489. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Targadox?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Targadox NDC 69489-111 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69489-111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69489-0111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69489-111-05	6948901110569489011105	5 TABLET in 1 BOTTLE (69489-111-05)Marketed from Aug 29, 2016
69489-111-60	6948901116069489011160	60 TABLET in 1 BOTTLE (69489-111-60)Marketed from Aug 29, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Targadox
Generic name (nonproprietary): doxycycline hyclate
Active ingredients: Doxycycline hyclate — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Journey Medical CorporationNDC labeler code 69489
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 062269
Marketing start: Aug 29, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 69489-111_f6381a8c-2611-4758-9208-1bc746e01ca3SPL ID f6381a8c-2611-4758-9208-1bc746e01ca3SPL set ID 83243f78-b984-46a4-a88a-c6a15c217b90RxCUI 1652674, 1806948UNII 19XTS3T51UUPC 0369489111059, 0369489111608
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469489011105 followed by a unit qualifier and the quantity

Package 69489-0111-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 21, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of TARGADOX ® and other antibacterial drugs, TARGADOX ® should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Treatment: Doxycycline is indicated for the treatment of the following infections: • Rocky Mountain spotted fever, typhus fever and the typhus group, Q f…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69489-111

What is NDC 69489-111?: 69489-111 is the product NDC for Targadox (doxycycline hyclate), Doxycycline hyclate 50 mg/1 tablet, listed with the FDA by Journey Medical Corporation. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Targadox (Doxycycline hyclate).
What is the active ingredient?: Doxycycline hyclate.
Who is the labeler?: Journey Medical Corporation, NDC labeler code 69489. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Targadox?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 062269

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 062269
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-310
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	Health Department, Oklahoma State	83112-100
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4510
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-3214
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	Redpharm Drug	67296-2189
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	Epic Pharma, LLC	42806-310
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7800
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7546
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7547
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals,Inc.	68071-4836
Doxycycline Hyclate	Doxycycline hyclate 50 mg/1	Tablet, Film coatedOral	JG Pharma Inc.	72143-262

Targadox (Doxycycline hyclate) NDC 69489-111